Trials / Completed
CompletedNCT00521131
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
Evaluation of Efficacy, Using the Number of Comfortable Days and the Safety of Levocetirizine Dihydrochloride, Administered Once Daily in the Evening for 30 Days, to Subjects Suffering From Perennial Allergic Rhinitis to House Dust Mites
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 453 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine dihydrochloride |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2003-05-01
- Completion
- 2003-05-01
- First posted
- 2007-08-27
- Last updated
- 2013-12-16
Source: ClinicalTrials.gov record NCT00521131. Inclusion in this directory is not an endorsement.